ESPE2021 ePoster Category 1 Thyroid A (10 abstracts)
1Department of Pediatric Endocrinology, Emma Childrens Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands; 2Department of Pediatric Surgery, Emma Childrens Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands
Background: Transient or permanent hypoparathyroidism is one of the most well-known complications of total thyroidectomy and may lead to symptomatic hypocalcaemia. Treatment of post-thyroidectomy hypocalcaemia usually consists of postoperative calcium and/or vitamin D supplementation. In 2013 we implemented prophylactic pre-thyroidectomy calcitriol supplementation for all children undergoing total thyroidectomy at Amsterdam UMC. The objective of this study was to evaluate the efficacy of this prophylactic calcitriol supplementation in preventing post-thyroidectomy hypocalcaemia in children.
Methods: In a retrospective case study we included all children (age < 18 years), who underwent a (sub)total or completion thyroidectomy in Amsterdam UMC, between 2000 and 2020. Patients were divided into two groups, patients with preoperative calcitriol supplementation, and those without (controls). Hypocalcaemia was defined as total serum calcium concentration of < 2.0 mmol/l. Primary outcome measure was the occurrence of hypocalcaemia in the first 72 hours after surgery. Secondary outcome measures were occurrence of symptomatic hypocalcaemia, need for medical intervention for hypocalcaemia and length of hospitalization.
Results: A total of 51 patients were included; 26 with calcitriol prophylaxis and 25 controls. There was no significant difference in occurrence of hypocalcaemia (17/26 prophylaxis group; 18/25 control group). Median post-operative calcium concentrations in the first 72 hours were significantly higher in the group with prophylaxis at 12-17 hours after surgery (2.12 vs 1.96 mmol/l), 30-35 hours (2.26 vs 2.01 mmol/l) and 36-41 hours (2.17 vs 1.92 mmol/l). Occurrence of symptomatic hypocalcaemia, need for medical intervention and length of hospitalization were not significantly different between the groups (Table).
Calcitriol prophylaxis (n = 26) | Controls (n = 25) | P-value | |
Age at surgery in years (median, range) | 14 (3-17) | 13 (1-17) | 0.828 |
Indication for surgery | |||
Prophylactic | 2 | 6 | 0.276 |
Benign disease | 13 | 9 | |
Malignant disease | 11 | 10 | |
Extent of surgery | 0.564 | ||
Hypocalcaemia < 72 hours | 17 | 18 | 0.764 |
Symptomatic hypocalcaemia < 72 hours | 6/17 | 5/18 | 1.000 |
Permanent hypocalcaemia | 5 | 9 | 0.305 |
Length of hospitalization in days (median, range) | 3 (2-8) | 3 (2-10) | 0.356 |
Conclusion: While calcitriol prophylaxis resulted in somewhat higher postoperative calcium concentrations, it did not reduce the occurrence of hypocalcaemia and did not affect clinical outcome measures such as occurrence of symptomatic hypocalcaemia and length of postoperative hospitalization.